J A Berzofsky

1.8k total citations
38 papers, 1.5k citations indexed

About

J A Berzofsky is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J A Berzofsky has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J A Berzofsky's work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Malaria Research and Control (6 papers). J A Berzofsky is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Malaria Research and Control (6 papers). J A Berzofsky collaborates with scholars based in United States, Japan and Australia. J A Berzofsky's co-authors include Martha A. Alexander‐Miller, Graham R. Leggatt, Frank R.N. Gurd, Ira Berkower, Richard A. Houghten, Michael F. Good, Isabella A. Quakyi, L H Miller, Howard Streicher and MP Busch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

J A Berzofsky

36 papers receiving 1.5k citations

Peers

Countries citing papers authored by J A Berzofsky

Since Specialization

Citations

This map shows the geographic impact of J A Berzofsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Berzofsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Berzofsky more than expected).

Fields of papers citing papers by J A Berzofsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Berzofsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Berzofsky. The network helps show where J A Berzofsky may publish in the future.

Co-authorship network of co-authors of J A Berzofsky

This figure shows the co-authorship network connecting the top 25 collaborators of J A Berzofsky. A scholar is included among the top collaborators of J A Berzofsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Berzofsky. J A Berzofsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of 3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs 2007 ·International Immunology ·Igor M. Belyakov, Steven Kozlowski, Michael G. Mage, Judith Ahlers, Lisa F. Boyd, David H. Margulies, J A Berzofsky	6
2	Autologous PBMCs pulsed with HPV16 E6 as an immunotherapeutic agent for patients with advanced cervical cancer 2005 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Barry L. Gause, Sarah Bernstein, Frank Grollman, (unknown), Susanne Steinberg, J A Berzofsky, Samir N. Khleif	3
3	Mutant P53 vaccination of patients with advanced cancers generates specific immunological responses 2004 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J A Berzofsky, (unknown)	4
4	Human Immunodeficiency Virus Type 1 (HIV-l)-Seronegative Injection Drug Users at Risk for HIV Exposure Have Antibodies to HLA Class I Antigens and T Cells Specific for HIV Envelope 1996 ·The Journal of Infectious Diseases ·A. Beretta, Stanley H. Weiss, Giovanna Rappocciolo, (unknown), C. De Santis, (unknown), Antonio Cosma, Piera Robbioni, G M Shearer, J A Berzofsky, Maria Luisa Villa, A. G. Siccardi, Mario Clerici	41
5	Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma 1996 ·Hepatology ·Kazutaka Kurokohchi, Mary Carrington, Dean L. Mann, Toni B. Simonis, Martha A. Alexander‐Miller, S M Feinstone, Toshitaka Akatsuka, J A Berzofsky	68
6	Cross-fertilization among fields: a seminal event in the progress of biomedical research. 1994 ·Journal of Clinical Investigation ·J A Berzofsky	5
7	HIV-specific T helper activity in HIV seronegative health care workers accidentally exposed to HIV-contaminated blood 1994 ·Mario Clerici, (unknown), (unknown), Ad Harris, J A Berzofsky, Alan Landay, G M Shearer	6
8	Demonstration of Human T Lymphotropic Virus Type I (HTLV-I)-Specific T Cell Responses from Seronegative and Polymerase Chain Reaction-Negative Persons Exposed to HTLV-I 1994 ·The Journal of Infectious Diseases ·Mayumi Nishimura, Allan G. Kermode, Mario Clerici, G M Shearer, J A Berzofsky, Takashi Uchiyama, (unknown), (unknown), Bryan Maloney, A Manns, William A. Blattner, Steven Jacobson	10
9	Development of a Malaria T‐Cell Vaccine for Blood Stage Immunity 1992 ·Scandinavian Journal of Immunology ·Isabella A. Quakyi, Diane Wallace Taylor, A.H. Johnson, (unknown), J A Berzofsky, Louis H. Miller, Michael F. Good	7
10	Molecular Structure and Vaccine Design 1990 ·PubMed ·Sándor Vajda, Ryoichi Kataoka, Charles DeLisi, Hanah Margalit, J A Berzofsky, James Cornette	7
11	Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. 1990 ·The Journal of Immunology ·Joseph M. Vinetz, Sanjeev Kumar, (unknown), B. J. Fowlkes, J A Berzofsky, L. H. Miller	60
12	A CTL epitope on the circumsporozoite protein of P. yoelii. 1990 ·PubMed ·Walter R. Weiss, R A Houghten, (unknown), J A Berzofsky, L H Miller, Stephen L. Hoffman	7
13	Genetic restriction of protective immunity to Plasmodium yoelii sporozoites. 1990 ·PubMed ·Walter R. Weiss, (unknown), Michael R. Hollingdale, Louis H. Miller, J A Berzofsky	2
14	Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design. 1988 ·PubMed ·J A Berzofsky	1
15	A comment on the commentary 1986 ·Immunogenetics ·(unknown), R Lieberman, (unknown), David H. Sachs, W E Paul, J A Berzofsky	1
16	Antigen conformation determines processing requirements for T-cell activation. 1984 ·Proceedings of the National Academy of Sciences ·Howard Streicher, Ira Berkower, MP Busch, Frank R.N. Gurd, J A Berzofsky	152
17	Genetic control of the immune response to myoglobins. Both low and high responder T cells tolerant to the other major histocompatibility complex help high but not low responder B cells 1982 ·The Journal of Experimental Medicine ·Yoichi Kohno, J A Berzofsky	6
18	Idiotypes of anti-myoglobin antibodies shared idiotypes among monoclonal antibodies to distinct determinants of sperm whale myoglobin 1982 ·The Journal of Immunology ·(unknown), (unknown), (unknown), J A Berzofsky	4
19	Ir genes of different high responder haplotypes for staphylococcal nuclease are not allelic. 1981 ·The Journal of Immunology ·J A Berzofsky, D S Pisetsky, (unknown), (unknown), D H Sachs	3
20	Genetic control of the immune response to staphylococcal nuclease. VII. Role of non-H-2-linked genes in the control of the anti-nuclease antibody response 1978 ·The Journal of Experimental Medicine ·D S Pisetsky, J A Berzofsky, D H Sachs	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact